VORN Bioenergy acquired the Hallertau biogas plant in Bavaria in May 2026. The purchase price was not disclosed. The operational plant has 95 GWh of annual capacity, with gas fed directly into the public grid. Longspur Capital advised on the transaction.

The core shift in Germany biogas M&A is buyer preference for operating assets with secured local feedstock. VORN is not buying generic biogas capacity. It is acquiring a plant linked to regional hop production, grid injection, and an existing logistics network.

The Hallertau plant is primarily supplied by shredded hop vines and agricultural by-products. Feedstock sourcing is supported through cooperation with Hopfenverwertungsgenossenschaft eG and local Högl Group companies. This lowers procurement risk and ties the asset to a regional circular-economy model.

VORN Bioenergy, a private biogas platform, is using acquisitions alongside new-build development to scale across Europe. The deal adds an operational German asset while complementing its Spanish development pipeline, where plants are expected to process olive oil pomace.

Buyer behavior is becoming more selective. Assets with grid access, recurring agricultural residue supply, and established operating partners are commercially stronger than standalone development projects.

For Germany biogas M&A, the signal is clear: operational plants with local waste streams and grid injection can attract platform buyers seeking contracted supply chains, not just capacity.

Want to track the latest M&A, financings, PPAs, and key developments across the industry? Explore the Enerdatics Insights page.